1. Lengauer, C., Kinzler, K. W. & Vogelstein, B. Genetic instability in colorectal cancers. Nature 386,623-7 (1997).
2. Lengauer, C., Kinzler, K. W. & Vogelstein, B. Genetic instabilities in human cancers. Nature 396,643-649 (1998).
3. Shih, I.-M. et al. Evidence That Genetic Instability Occurs at an Early Stage of Colorectal Tumorigenesis. Cancer Research 61, (2001).
4. Hveem, T. S. et al. Prognostic impact of genomic instability in colorectal cancer. British journal of cancer 110, 2159-2164 (2014).
5. Edwards, B. K. et al. Annual Report to the Nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer 94, 2766-2792 (2002).
6.Peto, J. Cancer epidemiology in the last century and the next decade. Nature 411, 390-395 (2001).
7.Bartkova, J. et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864-870 (2005).
8. Gorgoulis, V. G. et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434, 907-913 (2005).
9. Atsumi, Y. et al. Onset of Quiescence Following p53 Mediated Down-Regulation of H2AX in Normal Cells. PLoS ONE6, e23432 (2011).
10. Connor, F. et al. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation.Nature Genetics 17, 423-430 (1997).
11. Moynahan, M. E., Chiu, J. W., Koller, B. H., Jasin, M. & Jasint, M. Brcal Controls Homology-Directed DNA Repair. Molecular Cell4, 511-518 (1999).
12. Campisi, J. & D'Adda Di Fagagna, F. Cellular senescence: When bad things happen to good cells.Nature Reviews Molecular Cell Biology 8, 729-740 (2007).
13. Sharpless, N. E. & Sherr, C. J. Forging a signature of in vivo senescence. Nature Reviews Cancer 15,397-408 (2015).
14. Terzi, M. Y., Izmirli, M. & Gogebakan, B. The cell fate: senescence or quiescence. Molecular Biology Reports 43, 1213-1220 (2016).
15. Yoshioka, K. I., Atsumi, Y., Fukuda, H., Masutani, M. & Teraoka, H. The quiescent cellular state is Arf/p53-dependent and associated with H2AX downregulation and genome stability. International journal of molecular sciences 13, 6492-506 (2012).
16. Yoshioka, K., Atsumi, Y., Nakagama, H. & Teraoka, H. Development of cancer-initiating cells and immortalized cells with genomic instability. World Journal of Stem Cells 7, 483 (2015).
17. Grudzenski, S., Raths, A., Conrad, S., Rube, C. E. & Lobrich, M. Inducible response required for repair of low-dose radiation damage in human fibroblasts. Proceedings of the National Academy of Sciences 107, 14205-14210 (2010).
18. Sedelnikova, O. A. et al. Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nature Cell Biology 6, 168-170 (2004).
19. Campisi, J. Aging, cellular senescence, and cancer. Annual Review of Physiology 75, 685-705 (2013).
20. Kulju, K. S. & Lehman, J. M. Increased p53 protein associated with aging in human diploid fibroblasts. Experimental Cell Research 217, 336-345 (1995).
21. Sabin, R. J. & Anderson, R. M. Cellular Senescence - its role in cancer and the response to ionizing radiation. Genome Integrity 2, (2011).
22. Sager, R. Senescence as a mode of tumor suppression. Environmental Health Perspectives 93, 59-62 (1991).
23. Lecot, P., Alimirah, F., Desprez, P.-Y. Y., Campisi, J. & Wiley, C. Context-dependent effects of cellular senescence in cancer development. British Journal of Cancer 114, 1180-1184 (2016).
24. Mosieniak, G. & Sikora, E. Polyploidy: The Link Between Senescence and Cancer. Current Pharmaceutical Design 16, 734-740 (2010).
25. van Riggelen, J. & Felsher, D. W. My and a Cdk2 senescence switch. Nature Cell Biology 12, 7-9(2010).
26. The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330-337 (2012).
27. Poulogiannis, G., Frayling, I. M. & Arends, M. J. DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome. Histopathology vol. 56 167-179 John Wiley & Sons, Ltd, 2010).
28. Gologan, A. & Sepulveda, A. R. Microsatellite instability and DNA mismatch repair deficiency testing in hereditary and sporadic gastrointestinal cancers. Clinics in Laboratory Medicine 25, 179-196 (2005).
29. Woerner, S. M., Kloor, M., von Knebel Doeberitz, M. & Gebert, J. F. Microsatellite instability in the development of DNA mismatch repair deficient tumors. Cancer Biomark 2, 69-86 (2006).
30. Geigl, J. B., Obenauf, A. C., Schwarzbraun, T. & Speicher, M. R. Defining "chromosomal instability.Trends in Genetics 24, 64-69 (2008).
31. Almoguera, C. et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes.Cell 53, 549-554 (1988).
32. Williams, C. et al. Clones of Normal Keratinocytes and a Variety of Simultaneously Present Epidermal Neoplastic Lesions Contain a Multitude of p53 Gene Mutations in a Xeroderma Pigmentosum Patient. Cancer Research 58, (1998).
33. Nowell, P. C. Genetic alterations in leukemias and lymphomas: Impressive progress and continuing complexity. Cancer Genetics and Cytogenetics 94, 13-19 (1997).
34. Thiagalingam, S. et al. Mechanisms underlying losses of heterozygosity in human colorectal cancers.Proceedings of the National Academy of Sciences of the United States of America 98, 2698-2702(2001).
35.Baca, S. C. et al. Punctuated evolution of prostate cancer genomes. Cell 153, 666-677 (2013).
36.Stephens, P. J. et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144, 27-40 (2011).
37. Ichijima, Y. et al. DNA lesions induced by replication stress trigger mitotic aberration and tetraploidy development. PLoS ONE5, e8821 (2010).
38. Fujimori, H., Shikanai, M., Teraoka, H., Masutani, M. & Yoshioka, K. I. Induction of cancerous stem cells during embryonic stem cell differentiation. Journal of Biological Chemistry 287, 36777-36791(2012).
39. Osawa, T. et al. Arf and p53 act as guardians of a quiescent cellular state by protecting against immortalization of cells with stable genomes. Biochemical and Biophysical Research Communications 432, 34-39 (2013).
40. Hoeijmakers, J. H. J. DNA Damage, Aging, and Cancer. New England Journal of Medicine 361,1475-1485 (2009).
41. Sebastian, R. & Raghavan, S. C. Induction of DNA damage and erroneous repair can explain genomic instability caused by endosulfan. Carcinogenesis 37, 929-940 (2016).
42. Ciccia, A. & Elledge, S. J. The DNA Damage Response: Making It Safe to Play with Knives. Molecular Cell 40, 179-204 (2010).
43. Roos, W. P. & Kaina, B. DNA damage-induced cell death by apoptosis. Trends in Molecular Medicine vol. 12 440-450 (Elsevier Current Trends, 2006).
44. Stucki, M. & Jackson, S. P. y H2AX and MDC1: Anchoring the DNA-damage-response machinery to broken chromosomes. DNA Repair 5, 534-543 (2006).
45. Bonner, W. M. et al. y H2AX and cancer. Nature Reviews Cancer 8, 957-967 (2008).
46. Atsumi, Y. et al. ATM and SIRT6/SNF2H Mediate Transient H2AX Stabilization When DSBs Form by Blocking HUWE1 to Allow Efficient y H2AX Foci Formation. Cell reports 13, 2728-40 (2015).
47. Aguilera, A. & García-Muse, T. Causes of Genome Instability. Annual Review of Genetics 47, 1-32(2013).
48. Gaillard, H., García-Muse, T. & Aguilera, A. Replication stress and cancer. Nature Reviews Cancer 15, (2015).
49. Mazouzi, A., Velimezi, G. & Loizou, J. I. DNA replication stress: Causes, resolution and disease. Experimental Cell Research vol. 329 85-93 (Academic Press Inc., 2014).
50. Atsumi, Y. et al. The Arf/p53 Protein Module, Which Induces Apoptosis, Down-regulates Histone H2AX to Allow Normal Cells to Survive in the Presence of Anti-cancer Drugs. Journal of Biological Chemistry 288, 13269-13277 (2013).
51. Anderson, G. R. et al. Intrachromosomal Genomic Instability in Human Sporadic Colorectal Cancer Measured by Genome-Wide Allelotyping and Inter-(Simple Sequence Repeat) PCR. Cancer Research 61, (2001).
52. Zeman, M. K. & Cimprich, K. A. Causes and consequences of replication stress. Nature cell biology 16, 2-9 (2014).
53. Abbas, T., Keaton, M. A. & Dutta, A. Genomic instability in cancer. Cold Spring Harbor Perspectives in Biology 5, (2013).
54. Sedelnikova, O. A. et al. Delayed kinetics of DNA double-strand break processing in normal and pathological aging. Aging Cell7, 89-100 (2008).
55. Minakawa, Y., Atsumi, Y., Shinohara, A., Murakami, Y. & Yoshioka, K. I. Gamma-irradiated quiescent cells repair directly induced double-strand breaks but accumulate persistent double-strand breaks during subsequent DNA replication. Genes to Cells 21, 789-797 (2016).
56.Rao, C. v. & Yamada, H. Y. Genomic instability and colon carcinogenesis: From the perspective of genes. Frontiers in Oncology 3 MAY, (2013).
57. Blokzijl, F. et al. Tissue-specific mutation accumulation in human adult stem cells during life. Nature538, 260-264 (2016).
58. Martincorena, I. & Campbell, P. J. Somatic mutation in cancer and normal cells. Science 349, 1483-1489 (2015).
59.Tomasetti, C. & Vogelstein, B. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science 347, 78-81 (2015).
60. Kane, D. P. & Shcherbakova, P. v. A common cancer-associated DNA polymerase & mutation causes an exceptionally strong mutator phenotype, indicating fidelity defects distinct from loss of proofreading. Cancer Research 74, 1895-1901 (2014).
61. Rayner, E. et al. A panoply of errors: Polymerase proofreading domain mutations in cancer. Nature Reviews Cancer 16, 71-81 (2016).
62. Caldwell, C. M., Green, R. A. & Kaplan, K. B. APC mutations lead to cytokinetic failures in vitro and tetraploid genotypes in Min mice. Journal of Cell Biology 178, 1109-1120 (2007).
63. Ceol, C. J., Pellman, D. & Zon, L. I. APC and colon cancer: Two hits for one. Nature Medicine 13,1286-1287 (2007).
64. Dikovskaya, D. et al. Loss of APC induces polyploidy as a result of a combination of defects in mitosis and apoptosis. Journal of Cell Biology 176, 183-195 (2007).
65. Nik-Zainal, S. et al. Mutational Processes Molding the Genomes of 21 Breast Cancers. Cell 149,979-993 (2012).
66.Bartek, J. & Lukas, J. Pathways governing G1/S transition and their response to DNA damage. FEBSLetters 490, 117-122 (2001).
67. Sasaki, R. et al. Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes. Carcinogenesis 30, 423-431 (2009).
68. Bass, A. J. et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nature Genetics 41, 1238-1242 (2009).
69. Felsher, D. W. & Bishop, J. M. Reversible tumorigenesis by MYC in hematopoietic lineages.Molecular Cell4, 199-207 (1999).
70. Gidekel, S., Pizov, G., Bergman, Y. & Pikarsky, E. Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 4, 361-370 (2003).
71. Takahashi, K. & Yamanaka, S. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors. Cell 126, 663-676 (2006).
72. Keath, E. J., Caimi, P. G. & Cole, M. D. Fibroblast lines expressing activated c-myc oncogenes are tumorigenic in nude mice and syngeneic animals. Cell39, 339-348 (1984).
73. D'Cruz, C. M. et al. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nature Medicine 7, 235-239 (2001).
74. Lavialle, C., Modjtahedi, N., Cassingena, R. & Brison, O. High c-myc amplification level contributes to the tumorigenic phenotype of the human breast carcinoma cell line SW 613-S. Oncogene 3, 335-339 (1988).
75. Pu, H. et al. CUDR promotes liver cancer stem cell growth through upregulating TERT and C-Myc.Oncotarget 6, 40775-40798 (2015).
76. Narisawa-Saito, M. et al. HPV16 E6-mediated stabilization of ErbB2 in neoplastic transformation of human cervical keratinocytes. Oncogene 26, 2988-2996 (2007).
77. Zindy, F. et al. My signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes and Development 12, 2424-2433 (1998).
78. Lasry, A. & Ben-Neriah, Y. Senescence-associated inflammatory responses: Aging and cancer perspectives. Trends in Immunology 36, 217-228 (2015).
79. Collado, M. & Serrano, M. Senescence in tumours: Evidence from mice and humans. Nature Reviews Cancer 10, 51-57 (2010).
80.Lamm, N. et al. Genomic Instability in Human Pluripotent Stem Cells Arises from Replicative Stress and Chromosome Condensation Defects. Cell Stem Cell18, 253-261 (2016).
81. Courtois-Cox, S., Jones, S. L. & Cichowski, K. Many roads lead to oncogene-induced senescence.Oncogene 27, 2801-2809 (2008).
82. Galanos, P. et al. Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing. Nature Cell Biology 18, 777-789 (2016).
83. Knoepfler, P. S. Deconstructing stem cell tumorigenicity: A roadmap to safe regenerative medicine. Stem Cells 27, 1050-1056 (2009).
84. Mosteiro, L. et al. Tissue damage and senescence provide critical signals for cellular reprogramming in vivo. Science 354, (2016).
85. Grivennikov, S. I. & Karin, M. Inflammatory cytokines in cancer: Tumour necrosis factor and interleukin 6 take the stage. Annals of the Rheumatic Diseases 70, (2011).
86. Sethi, G., Sung, B. & Aggarwal, B. B. TNF: A master switch for inflammation to cancer. Frontiers in Bioscience 13, 5094-5107 (2008).
87. Cooks, T. et al. Mutant p53 Prolongs NF-к B Activation and Promotes Chronic Inflammation andInflammation-Associated Colorectal Cancer. Cancer Cell 23, 634-646 (2013).
88. Taylor, B. J. M. et al. DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis. eLife 2013, (2013).
89. Vartanian, J. P. et al. Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis. PLoS Pathogens 6, 1-9 (2010).
90. Kang, C. et al. The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4. Science 349, (2015).
91. White, R. R. & Vijg, J. Do DNA Double- Strand Breaks Drive Aging? Molecular Cell 63, 729-738(2016).
92. Liu, C., la Rosa, S. & Hagos, E. G. Oxidative DNA damage causes premature senescence in mouse embryonic fibroblasts deficient for Krüppel-like factor 4. Molecular Carcinogenesis 54, 889-899(2015).
93. Gorbunova, V. & Seluanov, A. DNA double strand break repair, aging and the chromatin connection.Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis 788, 2-6 (2016).
94. Zhang, D. et al. Increased DNA damage and repair deficiency in granulosa cells are associated with ovarian aging in rhesus monkey. Journal of Assisted Reproduction and Genetics 32, 1069-1078(2015).
95. Haigis, M. C. & Sinclair, D. A. Mammalian sirtuins: Biological insights and disease relevance. Annual Review of Pathology: Mechanisms of Disease 5, 253-295 (2010).
96. Giblin, W., Skinner, M. E. & Lombard, D. B. Sirtuins: Guardians of mammalian healthspan. Trends in Genetics 30, 271-286 (2014).
97. Utani, K. et al. Phosphorylated SIRT1 associates with replication origins to prevent excess replication initiation and preserve genomic stability. Nucleic Acids Research 45, 7807-7824 (2017).
98. Mao, Z. et al. SIRT6 promotes DNA repair under stress by activating PARP1. Science 332, 1443-1446 (2011).
99. Toiber, D. et al. SIRT6 recruits SNF2H to DNA break sites, preventing genomic instability through chromatin remodeling. Molecular Cell 51, 454-468 (2013).
100. Tomasetti, C., Li, L. & Vogelstein, B. Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. Science 355, 1330-1334 (2017).
101. Matsuno, Y. et al. Replication stress triggers microsatellite destabilization and hypermutation leading to clonal expansion in vitro. Nature Communications 10, 3925 (2019).
102. Yokoyama, A. et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers.Nature 565, 312-317 (2019).
103. Gilbert, E. S. Ionising radiation and cancer risks: What have we learned from epidemiology?International Journal of Radiation Biology 85, 467-482 (2009).
104. Morgan, W. F. & Sowa, M. B. Non-targeted effects induced by ionizing radiation: Mechanisms and potential impact on radiation induced health effects. Cancer Letters 356, 17-21 (2015).
105. Cardis, E. et al. Cancer consequences of the Chernobyl accident: 20 years on. Journal of Radiological Protection 26, 127-140 (2006).
106. Suzuki, K., Ojima, M., Kodama, S. & Watanabe, M. Radiation-induced DNA damage and delayed induced genomic instability. Oncogene 22, 6988-6993 (2003).
107. Lomax, M. E., Folkes, L. K. & O'Neill, P. Biological Consequences of Radiation-induced DNADamage: Relevance to Radiotherapy. Clinical Oncology 25, 578-585 (2013).
108. Borrego-Soto, G. et al. Ionizing radiation-induced DNA injury and damage detection in patients with breast cancer. Genetics and Molecular Biology 38, 420-432 (2015).
109. Burhans, W. C. & Weinberger, M. DNA replication stress, genome instability and aging. Nucleic Acids Research 35, 7545-7556 (2007).
110. Georgakilas, A. G., O'Neill, P. & Stewart, R. D. Induction and Repair of Clustered DNA Lesions:What Do We Know So Far? Radiation Research 180, 100-109 (2013).
111. Sage, E. & Shikazono, N. Radiation-induced clustered DNA lesions: Repair and mutagenesis. Free Radical Biology and Medicine vol. 107 125-135 (2017).
112. Nickoloff, J. A., Sharma, N. & Taylor, L. Clustered DNA double-strand breaks: Biological effects and relevance to cancer radiotherapy. Genes vol. 11 (2020).
113. Burtt, J. J., Thompson, P. A. & Lafrenie, R. M. Non-targeted effects and radiation-induced carcinogenesis: a review. Journal of Radiological Protection 36, R23-R35 (2016).
114. Mirzayans, R., Andrais, B., Scott, A. & Murray, D. New insights into p53 signaling and cancer cell response to DNA damage: implications for cancer therapy. Journal of biomedicine & biotechnology 2012, 170325 (2012).
115. Shiloh, Y. & Ziv, Y. The ATM protein kinase: regulating the cellular response to genotoxic stress, and more. Nature Reviews Molecular Cell Biology 14, 197-210 (2013).
116. Matheu, A. et al. Delayed ageing through damage protection by the Arf/p53 pathway. Nature 448,375-379 (2007).
117. Toledo, L. I. et al. ATR Prohibits Replication Catastrophe by Preventing Global Exhaustion of RPA. Cell 155, 1088-1103 (2013).
118. Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415-421(2013).
119. Gorgoulis, V. et al. Cellular Senescence: Defining a Path Forward. Cell vol. 179 813-827 (2019).
120. Glück, S. et al. Innate immune sensing of cytosolic chromatin fragments through GAS promotes senescence. Nature Cell Biology 19, 1061-1070 (2017).
121. Dou, Z. et al. Cytoplasmic chromatin triggers inflammation in senescence and cancer. Nature 550,402-406 (2017).
122. Decout, A., Katz, J. D., Venkatraman, S. & Ablasser, A. The GAS-STING pathway as a therapeutic target in inflammatory diseases. Nature Reviews Immunology 2021 21:921, 548-569 (2021).
123. Bakhoum, S. F. et al. Chromosomal instability drives metastasis through a cytosolic DNA response.Nature 553, 467-472 (2018).
124. Dimri, G. P. et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proceedings of the National Academy of Sciences of the United States of America 92, 9363(1995).
125. Liao, E. C. et al. Radiation induces senescence and a bystander effect through metabolic alterations.Cell death & disease 5, e1255-1255 (2014).
126. Greaves, M. & Maley, C. C. Clonal evolution in cancer. Nature 481, 306-313 (2012).
127. McGranahan, N. & Swanton, C. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future. Cell168, 613-628 (2017).
128. Barnes, D. E. & Lindahl, T. Repair and genetic consequences of endogenous DNA base damage in mammalian cells. Annual Review of Genetics vol. 38 445-476 (2004).
129. Cui, Y. et al. BioCircos js: an interactive Circos JavaScript library for biological data visualization on web applications. Bioinformatics 32, 1740-1742 (2016).
130. Negrini, S., Gorgoulis, V. G. & Halazonetis, T. D. Genomic instability - an evolving hallmark of cancer. Nature Reviews Molecular Cell Biologyvol. 11 220-228 (2010).
131. Bartkova, J. et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444, 633-637 (2006).
132. Halazonetis, T. D., Gorgoulis, V. G. & Bartek, J. An Oncogene- Induced DNA Damage Model for Cancer Development. Science 319, 1352-1355 (2008).
133. Howitz, K. T. et al. Small molecule activators of sirtins extend Saccharomyces cerevisiae lifespan. Nature 425, 191-196 (2003).
134. Wood, J. G. et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature430, 686-689 (2004).
135. Valenzano, D. R. et al. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Current Biology 16, 296-300 (2006).
136. Yu, X. & Li, G. Effects of resveratrol on longevity, cognitive ability and aging-related histological markers in the annual fish Nothobranchius guentheri. Experimental Gerontology 47, 940-949(2012).
137. Rascón, B., Hubbard, B. P., Sinclair, D. A. & Amdam, G. V. The lifespan extension effects of resveratrol are conserved in the honey bee and may be driven by a mechanism related to caloric restriction. Aging 4, 499-508 (2012).
138. Bitterman, J. L. & Chung, J. H. Metabolic effects of resveratrol: Addressing the controversies.Cellular and Molecular Life Sciences 72, 1473-1488 (2015).
139. Soleas, G. J., Grass, L., Josephy, P. D., Goldberg, D. M. & Diamandis, E. P. A comparison of the anticarcinogenic properties of four red wine polyphenols. Clinical Biochemistry 35, 119-124 (2002).
140. Harper, C. E. et al. Resveratrol suppresses prostate cancer progression in transgenic mice.Carcinogenesis 28, 1946-1953 (2007).
141. Sengottuvelan, M. & Nalini, N. Dietary supplementation of resveratrol suppresses colonic tumour incidence in 1,2-dimethylhydrazine-treated rats by modulating biotransforming enzymes and aberrant crypt foci development. British Journal of Nutrition 96, 145 (2006).
142. Banerjee, S., Bueso-Ramos, C. & Aggarwal, B. B. Suppression of 7,12-dimethylbenz(a) anthracene-induced mammary carcinogenesis in rats by resveratrol: Role of nuclear factor- k B, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Research 62, 4945-4954 (2002).
143. Minakawa, Y., Shimizu, A., Matsuno, Y. & Yoshioka, K. Genomic Destabilization Triggered byReplication Stress during Senescence. Cancers 9, 159 (2017).
144. Baur, J. A. & Sinclair, D. A. Therapeutic potential of resveratrol: The in vivo evidence. Nature Reviews Drug Discovery vol. 5 493-506 (2006).
145. Zheng, S.-Q. et al. Chlorogenic Acid Extends the Lifespan of Caenorhabditis elegans via Insulin/IGF-1 Signaling Pathway. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 72, glw105 (2016).
146. Sur, S. & Panda, C. K. Molecular aspects of cancer chemopreventive and therapeutic efficacies of tea and tea polyphenols. Nutrition 43-44, 8-15 (2017).
147. Tajik, N., Tajik, M., Mack, I. & Enck, P. The potential effects of chlorogenic acid, the main phenolic components in coffee, on health: a comprehensive review of the literature. European Journal of Nutrition 56, 2215-2244 (2017).
148. Tani, H. et al. Pharmacokinetics and Safety of Resveratrol Derivatives in Humans after Oral Administration of Melinjo ( Gnetum gnemon L.) Seed Extract Powder. Journal of Agricultural and Food Chemistry 62, 1999-2007 (2014).
149. Hombauer, H., Srivatsan, A., Putnam, C. D. & Kolodner, R. D. Mismatch repair, but not heteroduplex rejection, is temporally coupled to DNA replication. Science (New York, N.Y.) 334,1713-6 (2011).
150. Hombauer, H., Campbell, C. S., Smith, C. E., Desai, A. & Kolodner, R. D. Visualization of EukaryoticDNA Mismatch Repair Reveals Distinct Recognition and Repair Intermediates. Cell147, 1040-1053(2011).
151. De Wind, N., Dekker, M., Berns, A., Radman, M. & Te Riele, H. Inactivation of the Mouse Msh2Gene Results in Mismatch Repair Deficiency, Methylation Tolerance, Hyperrecombination, and Predisposition to Cancer. Cell vol. 82 (1995).
152. Noh, K. T. et al. Resveratrol suppresses tumor progression via the regulation of indoleamine 2,3-dioxygenase. Biochemical and Biophysical Research Communications 431, 348-353 (2013).
153. Piao, J., Nakatsu, Y., Ohno, M., Taguchi, K. & Tsuzuki, T. Mismatch repair deficient mice show susceptibility to oxidative stress-induced intestinal carcinogenesis. International journal of biological sciences 10, 73-9 (2013).
154. Wu, S., Powers, S., Zhu, W. & Hannun, Y. A. Substantial contribution of extrinsic risk factors to cancer development. Nature 529, 43-47 (2016).
155. Tomasetti, C. et al. Role of stem-cell divisions in cancer risk. Nature 548, E13-E14 (2017).
156. Yoshioka, K., Matsuno, Y., Hyodo, M. & Fujimori, H. Genomic-Destabilization-AssociatedMutagenesis and Clonal Evolution of Cells with Mutations in Tumor- Suppressor Genes. Cancers 11,1643 (2019).
157. Kato, E., Tokunaga, Y. & Sakan, F. Stillenoids isolated from the seeds of Melinjo (Gnetum gnemonL.) and their biological activity. Journal of agricultural and food chemistry 57, 2544-2549 (2009).
158. Tang, Q. et al. Resveratrol-induced apoptosis is enhanced by inhibition of autophagy in esophageal squamous cell carcinoma. Cancer Letters 336, 325-337 (2013).
159. Chang, C.-H. et al. Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: A key role of AMPK and Akt/m TOR signaling. International Journal of Oncology 50, 873-882 (2017).
160. Turturro, A., Duffy, P., Hass, B., Kodell, R. & Hart, R. Survival Characteristics and Age-AdjustedDisease Incidences in C57BL/6 Mice Fed a Commonly Used Cereal-Based Diet Modulated by Dietary Restriction. The Journals of Gerontology: Series A 57, B379-B389 (2002).
161. Todaro, G., Green, H., Torado, G. J. & Green, M. D. Quantitative Studies of The Growth of Mouse Embryo Cells in Culture and Their Development Into Established Lines. The Journal of Cell Biology 17, 299-313 (1963).
162. Nik-Zainal, S. et al. Association of a germline copy number polymorphism of APOBEC3A and APOB3B with burden of putative APOBEC-dependent mutations in breast cancer. Nature Genetics 46, 487-491 (2014).
163. Nikkilä, J. et al. Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells. British Journal of Cancer 117, 113-123 (2017).
164. Schuster-Böckler, B. & Lehner, B. Chromatin organization is a major influence on regional mutation rates in human cancer cells. Nature 488, 504-507 (2012).
165. Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214-218 (2013).
166. Du, Q. et al. Replication timing and epigenome remodelling are associated with the nature of chromosomal rearrangements in cancer. Nature Communications 10, 416 (2019).
167. Beroukhim, R. et al. The landscape of somatic copy-number alteration across human cancers. Nature 463, 899-905 (2010).
168. Chan, Y. W., Fugger, K. & West, S. C. Unresolved recombination intermediates lead to ultra-fine anaphase bridges, chromosome breaks and aberrations. Nature Cell Biology 20, 92-103 (2018).
169. Nobori, T. et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368, 753-756 (1994).
170. Okamoto, A. et al. Mutations and altered expression of p16INK4 in human cancer. Proc. Nail. Acad. Sci. USA 91, 11045-11049 (1994).
171. Fargnoli, M. C. et al. CDKN2a/p16INK4a Mutations and Lack of p19ARF Involvement in Familial Melanoma Kindreds. Journal of Investigative Dermatology 111, 1202-1206 (1998).
172. Berggren, P. et al. Detecting homozygous deletions in the CDKN2A(p16(INK4a)) /ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR. Clinical Cancer Research 4, 441- 444 (2003).
173. Cleary, M. L. Oncogenic conversion of transcription factors by chromosomal translocations. Cel/vol. 66 619-622 (1991).
174. Downing, J. R. et al. Detection of the (11;22) (q24;q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction. The American journal of pathology 143, 1294-300 (1993).
175. Moynahan, M. E. & Jasin, M. Loss of heterozygosity induced by a chromosomal double-strand break. Proceedings of the National Academy of Sciences of the United States of America 94, 8988-93 (1997).
176. Abkevich, V. et al. Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer. British journal of cancer 107, 1776-82 (2012).
177. Peng, H. Q., Bailey, D., Bronson, D., Goss, P. E. & Hogg, D. Loss of heterozygosity of tumor suppressor genes in testis cancer. Cancer research 55, 2871-5 (1995).
178. Lange, S. S., Takata, K. & Wood, R. D. DNA polymerases and cancer. Nature Reviews Cancer 11, 96-110 (2011).
179. Goodman, M. F. & Woodgate, R. Translesion DNA polymerases. Cold Spring Harbor Perspectives in Biology 5, (2013).
180. Rada, C., Ehrenstein, M. R., Neuberger, M. S. & Milstein, C. Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. Immunity 9, 135-141 (1998).
181. Zeng, X. et al. DNA polymerase n is an A-T mutator in somatic hypermutation of immunoglobulin variable genes. Nature Immunology 2, 537-541 (2001).
182. Donehower, L. A. et al. Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas. Cell Reports 28, 1370-1384.5 (2019).
183. Shen, L., Kondo, Y., Hamilton, S. R., Rashid, A. & Issa, J. pierre J. p14 methylation in human colon cancer is associated with microsatellite instability and wild-type p53. Gastroenterology 124, 626-633 (2003).
184. Matsuno, Y. et al. Resveratrol and its Related Polyphenols Contribute to the Maintenance of Genome Stability. Scientific Reports 10, (2020).
論文の公開元へ
